H aiti is a unique country in the Americas because malaria is caused there mainly by Plasmodium falciparum. Despite chloroquine being used for treatment of malaria since 1955, P. falciparum is generally still susceptible to this drug (1). Thus, chloroquine, plus a single dose of the gametocytocidal drug primaquine, is still the first-line treatment for uncomplicated malaria in Haiti, as indicated by the ministry of health. This regimen began to be challenged 9 years ago after a study reported chloroquine-resistant
